Prostate Cancer - Results from #26000

Molecular characterization of neuroendocrine prostate cancer and identification of new drug targets - Abstract May 4, 2012

MRI and surveillance - Abstract May 4, 2012

Active surveillance in prostate cancer: Patient selection and triggers for intervention - Abstract May 4, 2012

High-risk prostate cancer: From definition to contemporary management - Abstract May 4, 2012

Two decades' experience with a prospective biobank for urologic oncology: Research, clinical care, and the patients' view - Abstract May 4, 2012

Open complete intrafascial nerve-sparing retropubic radical prostatectomy: Technique and initial experience - Abstract May 4, 2012

Longitudinal changes of benign prostate-specific antigen and [-2]proprostate-specific antigen in seven years in a community-based sample of men - Abstract May 3, 2012

Ten-year follow-up of neoadjuvant therapy with goserelin acetate and flutamide before radical prostatectomy for clinical T3 and T4 prostate cancer: Update on Southwest Oncology Group Study 9109 - Abstract May 3, 2012

Head to head comparison of nomograms predicting probability of lymph node invasion of prostate cancer in patients undergoing extended pelvic lymph node dissection - Abstract May 3, 2012

Incidence of fractures causing hospitalisation in prostate cancer patients: Results from the population-based PCBaSe Sweden - Abstract May 3, 2012

Docetaxel-based systemic chemotherapy in elderly Korean men with castration-resistant prostate cancer - Abstract May 3, 2012

Phase II trial of weekly ixabepilone in men with metastatic castrate-resistant prostate cancer (E3803): A Trial of the Eastern Cooperative Oncology Group - Abstract May 3, 2012

Dose reduction in LDR brachytherapy by implanted prostate gold fiducial markers - Abstract May 3, 2012

Multiple rechallenges for castration-resistant prostate cancer patients responding to first-line docetaxel: Assessment of clinical outcomes and predictive factors - Abstract May 3, 2012

Environmental exposures and prostate cancer - Abstract May 3, 2012

TGFβ1 SNPs and radio-induced toxicity in prostate cancer patients - Abstract May 3, 2012

Very late prostate cancer local recurrence 23 years after radical prostatectomy - Abstract May 2, 2012

Technical note: Suppression of artifacts arising from simultaneous cone-beam imaging and RF transponder tracking in prostate radiotherapy - Abstract May 2, 2012

Prospective preference assessment of patients' willingness to participate in a randomized controlled trial of intensity-modulated radiotherapy versus proton therapy for localized prostate cancer - Abstract May 2, 2012

Factors associated with diagnostic and treatment intervals for prostate cancer in Queensland, Australia: A large cohort study - Abstract May 2, 2012

Page 1301 of 1438